01858 CHUNLI MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 5.20X | Oper Margin | 27.8% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 26.1% |
| Total Debt/Equity | 0.0% | Return on Equity | 9.1% |
| Price/Book | 1.50X | Return on Assets | 7.4% |
| (HKD 13.070) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 303.37 | 132.92 | 306.22 | 345.01 | 394.28 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +128.2 | -56.6 | -11.3 | -12.5 | +17.2 |
| Earnings Per Share (HKD) | 0.791 | 0.347 | 0.798 | 0.9 | 1.14 |
| Earnings Per Share Growth (%) | +128.3 | -56.6 | -11.3 | -21.1 | +17.2 |
| Dividend Per Share (HKD) | 0.397 | 0.145 | 0.397 | 0.342 | 0.153 |
| P/E* (X) | 16.53 | 37.72 | 16.37 | 14.53 | 11.46 |
| Yield (%) | 3.04 | 1.11 | 3.04 | 2.62 | 1.17 |
| Dividend Share (%) | 50.25 | 41.88 | 49.73 | 38.01 | 13.39 |
| Book NAV (HKD) | 8.695 | 7.836 | 8.269 | 7.935 | 7.859 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,046 | 805.857 | +29.8 | 1,209 |
| Operating Result | 302.241 | 130.675 | +131.3 | 305.972 |
| Profit Before Taxation | 301.712 | 131.599 | +129.3 | 305.906 |
| Taxation | 29.087 | 6.938 | +319.2 | 28.088 |
| Profit /( Loss) After Taxation | 272.625 | 124.661 | +118.7 | 277.818 |
| Minority Interests | 0.083 | -0.327 | -125.4 | -0.006 |
| Net Profit | 272.542 | 124.988 | +118.1 | 277.824 |
| Earnings Per Share () | 0.7909 | 0.3465 | +128.3 | 0.7983 |
| Dividend Per Share () | 0.3974 | 0.1451 | +173.9 | 0.3970 |
| Announcement Date | 2026-03-30 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
